Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis Registry

Authors

Jonathan I. Silverberg, Department of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
Angel Cronin, CorEvitas, LLC, Waltham, Massachusetts.
Eric A. Jones, CorEvitas, LLC, Waltham, Massachusetts.
Swapna S. Dave, CorEvitas, LLC, Waltham, Massachusetts.
Robert R. McLean, CorEvitas, LLC, Waltham, Massachusetts.
Jeffrey Greenberg, CorEvitas, LLC, Waltham, Massachusetts.
Bruce Strober, Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Thomas Bieber, Department of Dermatology and Allergology, University Hospital of Bonn, Bonn, Germany.
Melinda Gooderham, SKiN Centre for Dermatology and Probity Medical Research, Peterborough, Canada.
Amy S. Paller, Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Eric L. Simpson, Department of Dermatology, Oregon Health & Science University, Portland, Oregon.

Document Type

Journal Article

Publication Date

6-1-2024

Journal

JAAD international

Volume

15

DOI

10.1016/j.jdin.2023.11.015

Keywords

QoL; atopic dermatitis; biologic therapy; biologics; outcomes; quality of life; small molecule therapy; treatment response

APA Citation

Silverberg, Jonathan I.; Cronin, Angel; Jones, Eric A.; Dave, Swapna S.; McLean, Robert R.; Greenberg, Jeffrey; Strober, Bruce; Bieber, Thomas; Gooderham, Melinda; Paller, Amy S.; and Simpson, Eric L., "Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis Registry" (2024). GW Authored Works. Paper 5200.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/5200

Department

Dermatology